Proceedings of the Consensus Meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 8, 2009, Pages 1199-1202

  Sastre, Xavier ^a   Chantada, Guillermo L ^b   Doz, François ^a   Wilson, Matthew W ^c,d   De Davila, Maria T G ^b   Rodríguez Galindo, Carlos ^d   Chintagumpala, Murali ^e   Chévez Barrios, Patricia ^e,f,g,h  

^a INSTITUT CURIE   (France)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER SIZE; CANCER STAGING; CHOROID TUMOR; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; ENUCLEATION; EYE EXAMINATION; HUMAN; INTERNATIONAL COOPERATION; MEDICAL PRACTICE; OPTIC NERVE; PRACTICE GUIDELINE; PROGNOSIS; RETINOBLASTOMA; SCLERA; CHILD; CLASSIFICATION; CONSENSUS DEVELOPMENT; METHODOLOGY; PATHOLOGY; PRESCHOOL CHILD; RETINA TUMOR; RISK ASSESSMENT; RISK FACTOR; STANDARD;

CHILD; CHILD, PRESCHOOL; EYE ENUCLEATION; HUMANS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RETINAL NEOPLASMS; RETINOBLASTOMA; RISK ASSESSMENT; RISK FACTORS;

EID: 69149089679     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Abramson DH. Retinoblastoma incidence in the United States. Arch Ophthalmol. 1990;108:1514.
2. Abramson DH, Schefler AC. Update on retinoblastoma. Retina. 2004;24: 828-848.
3. Zucker JM, Desjardins L, Doz F. Retinoblastoma [discussion in Eur J Cancer. 1998;34:1048-1049]. Eur J Cancer. 1998;34:1045-1048.
4. Antoneli CB, Steinhorst F, de Cássia Braga Ribeiro K, et al. Extraocular retinoblastoma: a 13-year experience. Cancer. 2003;98:1292-1298.
5. Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus. 2000;37(3):134-141.
6. Chantada GL, Doz F, Orjuela M, et al; for the International Retinoblastoma Staging Working Group. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer. 2007;50(3):692-694.
7. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120:923-931. (Pubitemid 34755545)
8. Chantada GL, Dunkel IJ, de Davila MT, et al. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol. 2004;88:1069-1073.
9. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer. 1996;77:1206-1213. (Pubitemid 26080915)
10. Shields CL, Shields JA, Baez K, et al. Optic nerve invasion of retinoblastoma: metastatic potential and clinical risk factors. Cancer. 1994;73:692-698. (Pubitemid 24046614)
11. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96:217-222.
12. Chantada GL, Dunkel IJ, Antoneli CB, et al. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Pediatr Blood Cancer. 2007;49(3):256-260.
13. Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY, Chévez-Barrios P. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med. 2006;130(11):1669-1672. (Pubitemid 44683795)